Bal Pharma Limited
Outcome of Board Meeting
01 / The disclosure
What the company shared
Bal Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 11, 2026.As intimated vide our letter dated November 03, 2026, Board of directors of the Company met on Wednesday, November 11, 2026 inter alia transacted the following business.1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company for Second quarter and Half year ended on 30th September, 2026. copy of the approved financial results together with the limited review report issued by the statutory auditors of the Company with unmodified opinion is enclosed. 2. Statement of Utilization of issue proceeds raised through Preferential Issue of Warrants and Statement of Material Deviation under Regulation 32(1) of the SEBI Listing Regulations Statement confirming that there is no deviation or variation in the utilization of these proceeds for the quarter ended September 30, 2026, is enclosed
A question for your research
Check the reporting period, standalone versus consolidated basis, units and prior-period comparability before using financial figures.
Disclosed period ended 2026-09-30 · Q2 FY2027The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106855599
- First collected
- 11 Nov 2026, 19:00 IST
- PDF extraction
- metadata_only